Cancer cells employ lipid droplets to survive toxic stress

Author:

Kostecka Laurie G.123ORCID,Mendez Sabrina12,Li Melvin124,Khare Pratik1,Zhang Cissy1,Le Anne1,Amend Sarah R.123ORCID,Pienta Kenneth J.1234

Affiliation:

1. Johns Hopkins School of Medicine Baltimore Maryland USA

2. Johns Hopkins School of Medicine, Cancer Ecology Center The James Brady Urological Institute Baltimore Maryland USA

3. Cellular and Molecular Medicine Program Johns Hopkins School of Medicine Baltimore Maryland USA

4. Pharmacology and Molecular Sciences Program Johns Hopkins School of Medicine Baltimore Maryland USA

Abstract

AbstractBackgroundLipid reprogramming is a known mechanism to increase the energetic demands of proliferating cancer cells to drive and support tumorigenesis and progression. Elevated lipid droplets (LDs) are a well‐known alteration of lipid reprogramming in many cancers, including prostate cancer (PCa), and are associated with high tumor aggressiveness as well as therapy resistance. The mechanism of LD accumulation and specific LD functions are still not well understood; however, it has been shown that LDs can form as a protective mechanism against lipotoxicity and lipid peroxidation in the cell.MethodsThis study investigated the significance of LDs in PCa. This was done by staining, imaging, image quantification, and flow cytometry analysis of LDs in PCa cells. Additionally, lipidomics and metabolomics experiments were performed to assess the difference of metabolites and lipids in control and treatment surviving cancer cells. Lastly, to assess clinical significance, multiple publicly available datasets were mined for LD‐related data.ResultsOur study demonstrated that prostate and breast cancer cells that survive 72 h of chemotherapy treatment have elevated LDs. These LDs formed in tandem with elevated reactive oxygen species levels to sequester damaged and excess lipids created by oxidative stress, which promoted cell survival. Additionally, by inhibiting diacylglycerol O‐acyltransferase 1 (DGAT1) (which catalyzes triglyceride synthesis into LDs) and treating with chemotherapy simultaneously, we were able to decrease the overall amount of LDs and increase cancer cell death compared to treating with chemotherapy alone.ConclusionsOverall, our study proposes a potential combination therapy of DGAT1 inhibitors and chemotherapy to increase cancer cell death.

Publisher

Wiley

Reference36 articles.

1. American Cancer Society. Cancer Facts and Figures 2023. 2023.

2. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

3. American Cancer Society. Key Statistics for Prostate Cancer—Prostate Cancer Facts.2023. Accessed February 7 2023.https://www.cancer.org/cancer/prostate-cancer/about/key-statistics.html

4. Convergent Evolution, Evolving Evolvability, and the Origins of Lethal Cancer

5. Hallmarks of Cancer: The Next Generation

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3